March #45 : Spin Doctors - by Bob Lederer

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Dog Days in Malibu

Breathless

Born in Flames

Gay Guru

Soldier of Fortune

Rare Gem

Marathon Man

On the Waterfront

Race With the Angels

Mean Streets

S.O.S.

To the Editor

Ticket to Ride

Death by Disclosure

Slip Off the Old Block

Poster of the Month: Ruff Times

FYI

Say What

HIV in the Hood

No Brownie Points

Grades for AIDS

French Twist

Southern Discomfort

Sister Act Up

Sister Act Up

POZ Biz

POZarazzi: Call It a Day

Verse: Terminal Girl

Primary Concerns

Obits

Naming Names

Fast Company

Junk Mail

Life After Legacy

Spin Doctors

PWAs’ Best Friend

What’s Up, Doc?

HIV’s Incredible Endgame

The ABCs of Baby AZT

Hit the Dirt

Selling Sustiva

Publish or Perish

Best of the Rest

Where to Find It

What a Waste

Full Disclosure

People, Their Pets and Pet Peeves

Parental Guidance

Aunt Evelyn's Letters



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

March 1999

Spin Doctors

by Bob Lederer

The recent hype accompanying the release of two nonprotease antiretrovirals, abacavir (Ziagen) and efavirenz (Sustiva), is another reminder of the importance of independent information sources. As usual, pharmaceutical PR machines have spun the modest results of small, short-term clinical trials into claims of extreme drug potency. Indeed, when combined with older meds, abacavir and efavirenz are each said to constitute possible “protease-sparing regimens” (see “Fast Company” and “Selling Sustiva” ). And again as usual, community-based AIDS treatment newsletters have, after carefully weighing the evidence, raised serious questions about the most extravagant and premature claims. So the lesson stands: When making important treatment decisions, don’t rely on glossy smiling-consumer drug ads, short news articles or even the facts offered by an overworked doctor. Dip into the library of national AIDS periodicals (see "Best of the Rest"), and check out some of the most in-depth and trustworthy information available anywhere.



[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    chrisf
    san jose
    California


    soy_Ric
    Rochester
    New York


    pevans
    San Francisco
    California


    pozsmith1
    East Bay
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.